8-K
filed May 29, 2026, 4:15 PM ET
ticker EDSA
CIK 0001540159
other
confidence high
sentiment neutral
materiality 0.30
Edesa Biotech shareholders approve equity plan amendment adding 750K shares
Edesa Biotech, Inc.
- Shareholders approved Plan Amendment increasing shares available for issuance by 750,000 and eliminating annual per participant option grant limit.
- All seven director nominees elected with over 2.6M votes for each; broker non-votes of ~2.15M on each.
- Advisory vote on executive compensation approved with 2.67M for, 69K against.
- Appointment of MNP LLP as auditors for FY2026 approved with 4.81M for.
- Approximately 55% of outstanding shares (4.9M shares) represented at the meeting.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001171843-26-003793
- form_type
- 8-K
- ticker
- EDSA
- cik
- 0001540159
- company_name
- Edesa Biotech, Inc.
- filed_at
- 2026-05-29T20:15:18+00:00
- discovered_at
- 2026-05-29T20:17:00.396982+00:00
- generated_at
- 2026-05-29T20:17:32.003178+00:00
- sec_items
- ["5.02", "5.07", "9.01"]
- event_type
- other
- sentiment
- neutral
- materiality_score
- 0.3
- calibrated_materiality_score
- 0.3
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001171843-26-003793
- json_url
- https://secwatch.observer/filing/0001171843-26-003793.json
- markdown_url
- https://secwatch.observer/filing/0001171843-26-003793.md
- text_url
- https://secwatch.observer/filing/0001171843-26-003793.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1540159/000117184326003793/0001171843-26-003793-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1540159/000117184326003793/f8k_052226.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
HAFC
Director Gideon Yu resigns from Hanmi board; stockholders approve 2026 ESPP
HANMI FINANCIAL CORP
May 27, 2026, 6:15 PM ET
other
Items 5.02, 5.07, 9.01
same SEC item: 5.02, 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
AXON
Axon shareholders elect all 9 director nominees and approve say-on-pay at 2026 annual meeting
AXON ENTERPRISE, INC.
June 1, 2026, 4:10 PM ET
other
Items 5.07, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
NRGV
Energy Vault shareholders elect three Class II directors and ratify BDO USA as auditor
Energy Vault Holdings, Inc.
June 1, 2026, 11:36 AM ET
other
Items 5.07, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
RUN
Sunrun annual meeting elects nine directors, approves say-on-pay, ratifies auditor
Sunrun Inc.
May 29, 2026, 6:01 PM ET
other
Items 5.07, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
HSTM
HealthStream: annual meeting votes pass; directors elected, auditor ratified, say-on-pay approved
HEALTHSTREAM INC
May 29, 2026, 4:34 PM ET
other
Items 5.07, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
LIF
Life360 shareholders elect four directors, approve say-on-pay, ratify Deloitte at annual meeting
Life360, Inc.
May 29, 2026, 4:18 PM ET
other
Items 5.07, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
MCS
Shareholders elect all 12 director nominees and approve say-on-pay and auditor ratification at annual meeting
MARCUS CORP
May 28, 2026, 6:11 PM ET
other
Items 5.07, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
RLMD
Relmada increases authorized common shares to 200M; stockholders approve 2021 Plan amendment
RELMADA THERAPEUTICS, INC.
May 28, 2026, 4:59 PM ET
other
Items 5.03, 5.07, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.